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Summary
Introduction: The association of squamous cell carcinoma of the larynx and chronic lymphocytic
leukemia (CLL) is exceptional. We report an observation of this association and present the
therapeutic problems as well as the effects on prognosis.
Observation: Direct laryngoscopy showed a tumor of the right hemilarynx, with the biopsy
concluding in moderately differentiated keratinizing squamous cell carcinoma. The patient
had a total laryngectomy, with bilateral lymph node evidement. The anatomopathological
examination of the operative specimen demonstrated inﬁltration of the larynx and squamous
cell carcinoma adenopathies and CLL. It was decided to monitor the chronic lymphoid leukemia,
classiﬁed as Binet stage B. The synchronous or metachronous onset of a second cancer in a
patient with CLL is more frequent than in the general population. The synchronous association
of squamous cell carcinoma of the larynx and CLL has been described only rarely. The thera-
peutic strategy should focus ﬁrst on the cancer with the shortest survival rate. The prognosis
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Introduction
Squamous cell carcinoma is the most frequent histological
form of malignant tumors of the larynx. Its association with
B-cell chronic lymphocytic leukemia (CLL) has only rarely
been reported in the literature [1].
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We report an exceptional observation of the association
f squamous cell carcinoma of the larynx and CLL. The latter
aised classiﬁcation and therapeutic management difﬁcul-
ies.
The objective of this study was to discuss the epidemio-
ogical characteristics of the association of larynx carcinoma
nd CLL, present the treatment problems as well as the
ffects on prognosis.bservation
he 75-year-old patient, a smoker of 80 packs a year
ith a history of coronary disease, consulted for dys-
served.
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Figure 1 Histological section showing proliferation of
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Figure 2 Histological section showing proliferation of
Malpighian cells arranged in mass associated with a proliferation
of small lymphocytic lymphocytes inﬁltrating the striated mus-
cle tissue and the right vocal cord (×400).
Table 1 Binet classiﬁcation.
Binet Characteristics: lymphocytosisa
A Adenopathies < 3 lymph node areasb
B Adenopathies≥ 3 lymph node areas
C Anemiac and/or thrombopeniad
a Lymphocytosis > 5 g/l presenting the phenotypical character-
istics of chronic lymphocytic leukemia (CLL).
b One area: cervical, axillary, uni- or bilateral inguinal, spleen,
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f small lymphocytic lymphocytes inﬁltrating the striated mus-
le tissue and the right vocal cord (×200).
honia evolving over 6months with undeﬁned weight
oss.
Examination showed a tumor of the right hemilarynx with
xity of the right vocal cord and bilateral upper and mid-
ervical jugulocarotid adenopathies.
Direct laryngoscopy demonstrated a tumor of the vocal
ord extending to the ventricle and the ventricular band
n the right side. The biopsy concluded in squamous cell
arcinoma. The cervical CT scan showed a hypodense
umor process invading the right glottosupraglottic region
ith involvement of the hyothyroepiglottic space and the
ight paraglottic region associated with bilateral cervical
denopathies. Staging (chest x-ray and cervical ultrasound)
as negative. The tumor was classiﬁed T3N2bM0. Total
aryngectomy with bilateral modiﬁed radical cervical evide-
ent was performed.
The anatomopathological examination of the operative
pecimen showed invasion of the right hemilarynx by a
oderately differentiated squamous cell carcinoma. How-
ver, there was a diffuse and nodular inﬁltration comprising
mall, mature monomorphic lymphocytes in the healthy
aryngeal tissue and in contact with the carcinomatous
roliferation (Figs. 1 and 2). Carcinomatous invasion with
apsular rupture was noted in two lymph nodes out of
8. None of the 38 lymph node samples on the left was
he seat of metastasis of the squamous cell carcinoma.
owever, all the lymph nodes with no carcinomatous inﬁl-
ration were the seat of diffuse lymphomatous proliferation,
ith the same characteristics as described for the larynx.
mmunophenotyping of the B lymphocytes concluded in B-
ell CLL.
The disease course was marked by the appearance on
he 15th postoperative day of left-sided submandibular and
nguinal adenopathies without hepatosplenomegaly.
The postoperative report found hyperleukocytosis at
0,000 with lymphocytosis at 15,000 lymphocytes/mm3 with
either anemia nor thrombopenia.
Imaging studies (cervical ultrasound and thoracoab-
ominopelvic CT) demonstrated several bilateral andliver.
c Hemoglobin < 100 g/l.
d Platelets < 100 g/l.
ediastinal submandibular adenopathies. This CLL was clas-
iﬁed stage B in the Binet classiﬁcation (Table 1).
Telecobalt therapy was used to deliver a 50-Gy dose in the
umor bed and in the cervical lymph node area at 2Gy per
ession and ﬁve sessions per week. The dose was completed
o 60Gy in the metastatic cervical lymph node areas with
apsular rupture. Chemotherapy was declined in this patient
ecause of his age and his cardiac disease.
iscussion
LL is a chronic hemopathy deﬁned by the accumulation
f small B lymphocytes in the blood and bone marrow,
ith a mature aspect of monoclonal origin presenting a
haracteristic phenotype. It is characterized by three major
istinctive traits:
1) it is not a proliferative disease but rather a dysregulation
of apoptosis. The best-known apoptosis inhibitor gene is
BCL-2, located on chromosome18. In CLL, this gene is
nearly always overexpressed. Its mechanism of action
remains unexplained and its involvement in apoptosis
inhibition has not been clariﬁed. However, this apoptosis
leads to an accumulation of B-cells;
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(2) autoimmune phenomena are frequent, mainly
directed against hematopoietic cells. Therefore, these
manifestations result from autoantibodies (polyclonal
immunoglobulins G). These autoantibodies are directed
against the hematopoietic cell lines and are responsible
for autoimmune hemolytic anemia, thrombopenia, and
more rarely autoimmune neutropenia;
(3) there is a severe immune deﬁcit, notably hypogamma-
globulinemia worsening as the disease progresses [2].
CLL is the most frequent leukemia in Western countries.
It increases with age, with the median age around 65 years.
Genetic factors seem to play a role in the pathogenesis of
the disease. Karyotype abnormalities are found in 50 to 80%
of cases. These abnormalities generally correspond to gains
or losses of genetic material. The 13q14 deletion is the most
frequent. The 11q22-23 deletions, trisomy 12, and p53 muta-
tion or deletion on chromosome17 are associated with more
aggressive forms [2].
CLL seems to favor the onset of synchronous or
metachronous epithelial cancers. A review of the literature
showed that in a population of 10,823 patients with CLL, 9%
developed a second synchronous or metachronous cancer
[3]. The association of CLL and squamous cell carcinomas
of the upper aerodigestive tract (UADT) is not exceptional.
Karchmer et al. reported a 6.8% rate of cancers preceding
or associated with leukemia, 22.5% of which were squamous
cell carcinomas of the UADT [4].
Synchronous or metachronous squamous cell carcinoma
of the larynx and CLL has rarely been reported in the litera-
ture [1,5,6]. In a Danish study, combining more than 12,000
patients with CLL, the onset of the second cancer was noted
in 1105 cases. In this group, the association of CLL and can-
cer of the larynx was observed in 0.8% of the cases [6].
Different hypotheses can explain the relation between
CLL and squamous cell carcinoma: alteration of antitumor
immunity related to the presence of CLL due to dysfunction
of the B-cells, a common etiological factor such as a
genetic predisposition [2], infection with an oncogene virus
(HPV-16, -11, -6 and HHV-8) [7], environmental exposure
to cancerigenic chemicals, and immunodepression induced
by chemotherapy [8]. The incidence of cervicofacial cancer
onset in immunodepressed patients (e.g., subjects having
received a transplant) varies in the literature from 1 to
2.4% with a follow-up of more than 10 years. The most
frequent histological type was squamous cell carcinoma
[9].
The relation between smoking and CLL has not been
proven, contrary to cancer of the larynx. However,
the high prevalence of secondary cancers (particularly
malignant tumors of the UADT, the pancreas, and the
urinary system) in patients with CLL can be explained by
smoking [6]. This tobacco intoxication was found in our
patient.
Synchronous involvement of the lymph nodes makes
clinical classiﬁcation of the lymph node involvement
difﬁcult. An anatomopathological examination in this case
provides precise lymph node staging [8]. Boddie et al.
encountered problems in lymph node classiﬁcation in 48%
of the cases in 20 patients with cervicofacial squamous cell
[155
arcinoma and CLL with cervical lymph node inﬁltration
10].
In general, in cases of synchronous tumors, the ﬁrst-line
reatment should focus on the tumor with the worst
rognosis. In synchronous CLL and cervicofacial squamous
ell carcinoma, treatment usually ﬁrst aims to ﬁght the
arcinoma [8].
In our case, CLL was discovered on the histological
xamination of a total laryngectomy associated with bilat-
ral functional curettage for a squamous cell carcinoma of
he larynx. The adjuvant treatment was prescribed for the
arcinomatous involvement.
onclusion
he association of CLL and UADT carcinomas has been well
ocumented in the literature. However, the simultaneous
oexistence of squamous cell carcinoma and CLL of the
arynx remains extremely rare. We have described this
ssociation through a case study involving both the larynx
nd the lymph nodes. CLL was discovered at the histological
xamination. The strategy in these cases consists in treating
he most aggressive cancer ﬁrst. The prognosis is more
egative compared to a single cancer of the larynx.
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